Announcements Trials
Browse Landscape

Phase

Phase NA 18Phase 4 5Phase 2 4Phase EARLY_PHASE1 3Phase 3 3Phase 2/3 2Phase 1 1

Status

Terminated 2Completed 2

Sponsor Class

OTHER 4

Study Type

Interventional 4

Sponsor

Cancer Type

Breast 2Tumor-Agnostic 1Gastrointestinal 1

Conditions

Carcinoma, Intraductal, Noninfiltrating 2Breast Neoplasms 2Stomach Neoplasms 1Neoplasms 1Esophageal Neoplasms 1Dyspareunia 1Breast Neoplasms, Male 1Breast Carcinoma In Situ 1Adenocarcinoma Of Esophagus 1

Interventions

Cisplatin 1041Cyclophosphamide 973Carboplatin 954Radiotherapy 893Bevacizumab 847Gemcitabine 817pembrolizumab 759Paclitaxel 738Docetaxel 734Oxaliplatin 706Capecitabine 649Fluorouracil 564Rituximab 559Nivolumab 506Dexamethasone 487Etoposide 468Doxorubicin 458Irinotecan 442Drug Therapy 402Leucovorin 377Cytarabine 342Cetuximab 340Lenalidomide 326Trastuzumab 323Pemetrexed 315durvalumab 295Filgrastim 287Magnetic Resonance Spectroscopy 278Temozolomide 275Prednisone 274

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

4 trials
RecentStart dateEnrollment
Phase 2 × OTHER × Fish Oils × Clear all
NCT01869764 2019-10-30

Omega-3 Fatty Acid in Treating Patients With Stage I-III Breast Cancer

Wake Forest University Health Sciences

Phase 2 Completed
57 enrolled 8 charts
Breast

Breast Carcinoma In Situ, Breast Neoplasms, Carcinoma, Intraductal, Noninfiltrating, Breast Neoplasms, Male

NCT02150525 2018-08-09

Effect of Omega 3 on Atrophic Vaginitis in Breast Cancer Survivors

Ohio State University Comprehensive Cancer Center

Phase 2 Completed
52 enrolled
Breast

Breast Neoplasms, Carcinoma, Intraductal, Noninfiltrating, Dyspareunia

NCT01325584 2018-08-07

Compassionate Use of OmegavenĀ® in the Treatment of Parenteral Nutrition Induced Hepatic Injury

Midwestern Regional Medical Center

Phase 2 Terminated
12 enrolled 10 charts
Tumor-Agnostic

Neoplasms

NCT01870791 2016-05-26

Study of Additive Omega-3 Fish Oil to Palliative Chemotherapy to Treat Oesophagogastric Cancer

University Hospitals, Leicester

Phase 2 Terminated
21 enrolled
Gastrointestinal

Adenocarcinoma Of Esophagus, Esophageal Neoplasms, Stomach Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚔